Page last updated: 2024-09-04

zopiclone n-oxide and Methemoglobinemia

zopiclone n-oxide has been researched along with Methemoglobinemia in 1 studies

*Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fung, HT; Kam, CW; Lai, CH; Lam, KK; Wong, OF1

Other Studies

1 other study(ies) available for zopiclone n-oxide and Methemoglobinemia

ArticleYear
Two cases of methemoglobinemia following zopiclone ingestion.
    Clinical toxicology (Philadelphia, Pa.), 2008, Volume: 46, Issue:2

    Topics: Adult; Azabicyclo Compounds; Drug Overdose; Enzyme Inhibitors; Female; Humans; Hypnotics and Sedatives; Methemoglobinemia; Methylene Blue; Molecular Structure; Piperazines; Tablets

2008